Swedbank
TEVA icon

Swedbank’s Teva Pharmaceuticals TEVA Stock Holding History

Swedbank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Buy
391,175
+10,909
+3% +$363K 0.01% 476
2026
Q1 		$11.5M Buy
+380,266
New +$12.2M 0.01% 468
2025
Q3 		– Sell
-110,653
Closed -$1.85M – 694
2025
Q2 		$1.85M Buy
110,653
+1,244
+1% +$20.1K ﹤0.01% 607
2025
Q1 		$1.68M Hold
109,409
– – ﹤0.01% 629
2024
Q4 		$2.41M Hold
109,409
– – ﹤0.01% 607
2024
Q3 		$1.97M Sell
109,409
-3,101
-3% -$54.3K ﹤0.01% 612
2024
Q2 		$1.83M Sell
112,510
-2,580
-2% -$39.7K ﹤0.01% 613
2024
Q1 		$1.62M Buy
115,090
+14,157
+14% +$178K ﹤0.01% 622
2023
Q4 		$1.05M Sell
100,933
-2,760
-3% -$25.8K ﹤0.01% 634
2023
Q3 		$1.06M Buy
+103,693
New +$966K ﹤0.01% 623
2021
Q2 		– Sell
-102,957
Closed -$1.19M – 767
2021
Q1 		$1.19M Buy
+102,957
New +$1.18M ﹤0.01% 667

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Swedbank's TEVA Position: Q2 2026 in Review

Swedbank increased its Teva Pharmaceuticals (TEVA) stake by 2.9% in Q2 2026, buying an estimated $363K and bringing the position to 391,175 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #476.

Swedbank first reported a position in TEVA in Q1 2021 and has held it in 11 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Swedbank held 391,175 shares of Teva Pharmaceuticals worth $13.3M as of Q2 2026.
  • Swedbank bought 10,909 Teva Pharmaceuticals shares in Q2 2026, an estimated $363K.
  • Teva Pharmaceuticals made up 0.01% of Swedbank's portfolio in Q2 2026, its #476 holding.
  • Swedbank first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 11 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.